Professor Gómez-Ruiz selected for the KERC Biotechnology Forum

The professor of Inorganic Chemistry at the Rey Juan Carlos University and prominent member of the Institute for Research on Technologies for Sustainability (ITPS), has been selected among the 24 European researchers invited to participate in the prestigious Korea-EU Horizon Europe Researchers Networking Forum on Advanced Biotechnology (KERC)

Newsroom

This selection, made from a large number of applications, reflects both the research excellence of Professor Santiago Gómez-Ruiz and the relevance of the lines of research he leads as principal investigator of the COMET-NANO group, focusing on nanomaterials with high-impact biomedical applications.

Organized by the Korea-EU Research Centre (KERC), the forum (held from July 1 to 3) aims to foster international consortia within the framework of Horizon Europe – Cluster 1: Health, with a focus on advanced therapies, personalized medicine, neurosciences, and emerging biomedical technologies. This event brings together leading researchers, cutting-edge institutions, and funding agencies from Europe and South Korea to foster strategic collaborations and the development of joint projects.

During his presentation, Professor Gómez-Ruiz presented the most innovative lines of research of the COMET-NANO group, with a special focus on the development of functional nanomaterials for the treatment of various diseases such as cancer, resistant bacterial infections, and neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). His team is working on intelligent nanostructures capable of controlled and selective drug release in different therapeutic environments, responding to different types of stimuli, offering nanoscience solutions for various current health problems.

This participation strengthens the international positioning of the URJC and its ITPS research institute as key players in the development of technological solutions for major global healthcare challenges. Furthermore, participation in this event opens up new opportunities for the creation of competitive European consortia, particularly in the field of applied medicine and diseases such as cancer, bacterial infections, and neurodegenerative disorders.

Recognized among the 2% of the world's most cited scientists, according to the ranking prepared by Stanford University and Elsevier, Professor Gómez-Ruiz consolidates with this invitation the URJC's prestige in the field of nanoscience and nanotechnology applied to advanced healthcare solutions.